Skip to search formSkip to main contentSkip to account menu

SR 58611

Known as: SR 58611A, SR-58611A 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The present study was designed to study the effect of SR 58611A, a selective Itl-adrenoceptor agonist against gastric ulcers… 
2004
2004
OBJECTIVE: To evaluate the gastroprotective effects of 3-adrenoceptor agonists CGP 12177A and SR 58611A, on water immersion plus… 
2003
2003
OBJECTIVE To investigate the functional expression of beta3-adrenoceptors (beta3-ARs) in equine digital veins (EDVs) and to… 
Review
1999
Review
1999
Although it is unclear to what extent irritable bowel syndrome (IBS) symptoms represent a normal perception of abnormal function… 
1997
1997
The beta 3-adrenoceptor (beta 3-AR) agonist SR-58611A {ethyl-[(7s)-7-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]5, 6,7,8… 
1994
1994
The beta-adrenoceptor subtypes involved in the control of lipolysis in white fat cells of rat, dog, marmoset (Callithrix jacchus… 
1994
1994
N(2S)-7-carbethoxymethoxy-1,2,3,4-tetrahydronaphth-2-yl]-(2R )-2-hydroxy-2-(3-chlorophenyl)ethanamine hydrochloride (SR 58611A… 
1991
1991
Inhibition of colonic myoelectric activity by the new atypical β‐adrenergic agonist SR 58611A and its cardiovascular effects were…